Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.
Faeth Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Faeth Therapeutics's investors include B Capital, Khosla Ventures, S2G Investments, KdT Ventures, Digitalis Ventures.
Faeth Therapeutics is headquartered in San Francisco, United States.
Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.
Faeth Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Faeth Therapeutics — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/faeth-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Faeth Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/faeth-therapeutics
{{cite web |title=Faeth Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/faeth-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated